Biotechnology and Skin Cancer Detection Markets

The global antibody production market is set to exceed USD 30.7 billion by 2031, driven by factors such as the increasing use of antibodies in therapeutic drugs, the rise in chronic diseases, and the emphasis on personalized medicines. Technological advancements in biotechnology are also contributing to the market's growth. On the other hand, the skin cancer detection devices market is expected to reach US$ 2.95 billion by 2033, fueled by growing awareness, technological advancements, and rising demand for early and accurate diagnosis. Major companies are investing in R&D efforts and forming strategic alliances to meet the growing market needs.